214 related articles for article (PubMed ID: 6943601)
21. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
[TBL] [Abstract][Full Text] [Related]
22. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
23. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
24. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
Saitoh S; Nakanishi A; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
[TBL] [Abstract][Full Text] [Related]
25. Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas.
Banyai A; Varga L; Barta A; Gopcsa L; Paloczi K
Cancer Immunol Immunother; 2004 Sep; 53(9):835-9. PubMed ID: 15052374
[TBL] [Abstract][Full Text] [Related]
26. Increase of serum complement levels in cancer patients with progressing tumors.
Verhaegen H; De Cock W; De Cree J; Verbruggen F
Cancer; 1976 Oct; 38(4):1608-13. PubMed ID: 991081
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
28. Determination of normal ranges for serum C3 and C4 levels in an adult Zimbabwean population.
Gomo R; Sibanda EN
Cent Afr J Med; 2002; 48(11-12):137-41. PubMed ID: 14562600
[TBL] [Abstract][Full Text] [Related]
29. Acute hepatitis: significance of changes in complement components.
Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
[TBL] [Abstract][Full Text] [Related]
30. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
[TBL] [Abstract][Full Text] [Related]
31. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
32. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
33. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
34. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
Lai A Fat RF; van Furth R
Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
[TBL] [Abstract][Full Text] [Related]
35. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
[TBL] [Abstract][Full Text] [Related]
36. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
38. [Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women].
Carranza Lira S; MacGregor Gooch AL; Olivares A; González Legorreta SL; Saldívar N; Martínez Chéquer JC
Ginecol Obstet Mex; 2005 Oct; 73(10):521-4. PubMed ID: 16583831
[TBL] [Abstract][Full Text] [Related]
39. Serum complement levels in patients with cancer of the uterine cervix before and after radiation therapy.
Pulay AT; Füst G; Csömör A
Neoplasma; 1980; 27(2):211-6. PubMed ID: 7393359
[TBL] [Abstract][Full Text] [Related]
40. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
